308 related articles for article (PubMed ID: 19444087)
1. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO
Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087
[TBL] [Abstract][Full Text] [Related]
2. Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation.
Andersson I; Ahlberg K; Stockelberg D; Persson LO
Eur J Cancer Care (Engl); 2011 May; 20(3):368-79. PubMed ID: 20345452
[TBL] [Abstract][Full Text] [Related]
3. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Ivanov V; Faucher C; Mohty M; Bilger K; Ladaique P; Sainty D; Arnoulet C; Chabannon C; Vey N; Camerlo J; Bouabdallah R; Maraninchi D; Bardou VJ; Blaise D
Transfusion; 2004 Apr; 44(4):501-8. PubMed ID: 15043564
[TBL] [Abstract][Full Text] [Related]
4. A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning.
Gupta V; Panzarella T; Li L; Khan J; Sharma A; Lipton JH; Kuruvilla J; Messner H; Alibhai SM
Biol Blood Marrow Transplant; 2012 Jan; 18(1):113-24. PubMed ID: 21703974
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.
Hjermstad MJ; Knobel H; Brinch L; Fayers PM; Loge JH; Holte H; Kaasa S
Bone Marrow Transplant; 2004 Aug; 34(3):257-66. PubMed ID: 15170167
[TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study.
Díez-Campelo M; Pérez-Simón JA; González-Porras JR; García-Cecilia JM; Salinero M; Caballero MD; Cañizo MC; Ocio EM; Miguel JF
Bone Marrow Transplant; 2004 Oct; 34(8):729-38. PubMed ID: 15354204
[TBL] [Abstract][Full Text] [Related]
7. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
[TBL] [Abstract][Full Text] [Related]
8. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation.
Tierney KD; Facione N; Padilla G; Blume K; Dodd M
Eur J Oncol Nurs; 2007 Sep; 11(4):298-308. PubMed ID: 17196431
[TBL] [Abstract][Full Text] [Related]
9. High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
El-Cheikh J; Michallet M; Nagler A; de Lavallade H; Nicolini FE; Shimoni A; Faucher C; Sobh M; Revesz D; Hardan I; Fürst S; Blaise D; Mohty M
Haematologica; 2008 Mar; 93(3):455-8. PubMed ID: 18287132
[TBL] [Abstract][Full Text] [Related]
10. Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Vaessen N; Claas EC; Barge RM; Kroes AC
Bone Marrow Transplant; 2007 Jul; 40(2):137-43. PubMed ID: 17530007
[TBL] [Abstract][Full Text] [Related]
11. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
12. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
[TBL] [Abstract][Full Text] [Related]
13. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Bevans MF; Marden S; Leidy NK; Soeken K; Cusack G; Rivera P; Mayberry H; Bishop MR; Childs R; Barrett AJ
Bone Marrow Transplant; 2006 Jul; 38(2):101-9. PubMed ID: 16751786
[TBL] [Abstract][Full Text] [Related]
15. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
[TBL] [Abstract][Full Text] [Related]
16. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
17. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens.
Omazic B; Hentschke P; Näsman-Björk I; Mattsson J; Oxelius VA; Ringdén O; Barkholt L; Permert J; Lundkvist I
Scand J Immunol; 2005 Jan; 61(1):72-81. PubMed ID: 15644125
[TBL] [Abstract][Full Text] [Related]
19. Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.
Frödin U; Lotfi K; Fomichov V; Juliusson G; Börjeson S
Eur J Cancer Care (Engl); 2015 Nov; 24(6):898-910. PubMed ID: 26156141
[TBL] [Abstract][Full Text] [Related]
20. Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
Huugen D; Schouten HC; Bos GM
Neth J Med; 2002 May; 60(4):162-9. PubMed ID: 12164394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
